Latest jobs
Salary:
Highly Competitive
Location:
Cambridge, England
An exciting opportunity has arisen for a Local Trial Manager to join a well-established pharmaceutical company.
Salary:
Highly Competitive
Location:
Maidenhead, England
A fantastic opportunity has arisen for a Senior PV Quality Assurance Manager.
Salary:
Highly Competitive
Location:
Wil, Switzerland
A vacancy has been announced for a Senior Quality Engineer with a global technology company entering the medical device industry.
Salary:
Highly Competitive
Location:
Basel, Switzerland
A pharmaceutical consultancy is looking for an experienced CRA (Clinical Research Associate) to join their team in Basel.
Salary:
Highly Competitive
Location:
Amsterdam, Netherlands
Proclinical has partnered with a Medical Communications company in London and Amsterdam
Salary:
Highly Competitive
Location:
Basel, Switzerland
Proclinical has partnered with biopharmaceutical company in search for a talented and dynamic Principle Biostatistician, to join their transnational science team.
Salary:
Highly Competitive
Location:
Surrey, England
An exciting part time opportunity has arisen for a Regulatory Consultant to join a popular pharmaceutical company in the UK.
Salary:
Highly Competitive
Location:
London, England
An amazing opportunity has arisen for a talented and experienced Key Account Manager (Oncology) in South London.
Salary:
Highly Competitive
Location:
Hertfordshire, England
Proclinical has partnered with a large pharmaceutical company in search for a Regulatory Affairs Consultant.
Salary:
Highly Competitive
Location:
Munich, Germany
An exciting opportunity has arisen for an experienced and talented Business Development Manager to join a dynamic team in Germany.
Salary:
Highly Competitive
Location:
Basel, Switzerland
A large pharmaceutical company is in search for an Analytical Project Leader (Scientist /Senior Scientist) to join their Molecules team.
Salary:
Highly Competitive
Location:
Belgium
We're currently searching for a Clinical Operations Administrator to support the launch of Phase II and Phase III.
